| Code | Description | Claims | Beneficiaries | Total Paid |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
14,582 |
14,423 |
$866K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
633 |
493 |
$439K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
2,217 |
1,816 |
$382K |
| J0178 |
Injection, aflibercept, 1 mg |
346 |
291 |
$269K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
3,735 |
3,718 |
$267K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
4,386 |
4,015 |
$206K |
| 92134 |
|
11,088 |
8,774 |
$177K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,041 |
2,027 |
$174K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,216 |
3,932 |
$169K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,975 |
2,740 |
$145K |
| 92015 |
Determination of refractive state |
10,082 |
10,014 |
$128K |
| 92083 |
|
2,071 |
1,747 |
$65K |
| 92133 |
|
3,231 |
2,677 |
$56K |
| 92136 |
|
3,780 |
1,386 |
$54K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
1,551 |
1,288 |
$44K |
| J7313 |
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg |
13 |
12 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
321 |
318 |
$19K |
| 92341 |
|
317 |
315 |
$11K |
| 92020 |
|
513 |
503 |
$6K |
| 92025 |
|
535 |
455 |
$5K |
| 92285 |
|
494 |
398 |
$5K |
| 92250 |
|
124 |
104 |
$3K |
| 66821 |
|
18 |
13 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40 |
40 |
$589.87 |
| 92081 |
|
31 |
27 |
$488.29 |
| 92082 |
|
16 |
13 |
$318.42 |
| 76514 |
|
75 |
65 |
$282.35 |
| 0356T |
|
21 |
15 |
$249.14 |